Ranibizumab for the Treatment of Diabetic Macular Oedema (TA274 [Rapid Review of TA237])
Technology Appraisal Guidance No. 274 Source: National Institute for Health and...
Jump to:
Technology Appraisal Guidance No. 276 Source: National Institute for Health and...
Technology Appraisal Guidance No. 274 Source: National Institute for Health and...
Technology Appraisal Guidance No. 275 Source: National Institute for Health and...
Technology Appraisal Guidance No. 194 Source: National Institute for Health and Clinical...
Technology Appraisal Guidance No. 273 Source: National Institute for Health and Clinical...
This activity will explore the latest data on the SGLT-2 inhibitors and implications for practice. Click here.
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.